Summary: A soluble somatostatin binding factor was detected in cell-free extracts from chicken pancreas. For binding measurements Tyr 1 -somatostatin was radio-labeled with 125 I by the lactoperoxidase technique. Specific radioactivity of about 18.5 MBq/nmol was achieved. Maximal total binding is approximately 0.17 ( ) in the presence of 30 mg/1 pancreatic protein. The specific binding is 0.10 and is suppressed by addition of 1 mg/1 synthetic cold cyclic somatostatin.
1
-somatostatin was radio-labeled with 125 I by the lactoperoxidase technique. Specific radioactivity of about 18.5 MBq/nmol was achieved. Maximal total binding is approximately 0.17 ( ) in the presence of 30 mg/1 pancreatic protein. The specific binding is 0.10 and is suppressed by addition of 1 mg/1 synthetic cold cyclic somatostatin.
The dose-response curve of synthetic cyclic somatostatin is in the range of 0.6-600 nmol/1. Ca 2 " 1 " and reduced thiolreagents inhibit the specific binding. Insulin, glucagon and corticotropin show a low, and luliberin and reduced somatostatin a high cross-reactivity. Molecular weight was estimated by gel filtration and the specific binding molecule was eluted at a K av = 0.2 on an Ultrogel® (AcA 54) column. This corresponds toM T 40 000. Electrophoretic properties of the binding complex and semipurification by polyacrylamide disc gel electrophoresis: relative mobility of the 12S I-Tyr-somatostatin binding complex is about 0.6. Relative mobilities of binding-protein fractions are 0.71 and 0.74. Highest relative specific binding was detected in the (100 000 g) cytosol fractions. Binding with cell-free extracts from the splenic lobe area was 4^fold higher than that from other parts of the chicken pancreas. 
Somatostatin-Bindungsfaktor aus Hühnerpankreas
Zusammenfassung
Introduction
Furthermore, a multitude of inhibiting effects of The tetradecapeptide somatostatin, which was originally somatostatin are well documented (for review: see I.e. identified in hypothalamic extracts, is distributed (7)). However, little is known about the mechanism of throughout the central nervous system, and is also found action of somatostatin at the cellular and subcellular in the gastrointestinal tract arid in the pancreas (1) (2) (3) (4) (5) (6) .
level. In this context it may be of importance that a 0340-076X/81/0019-0099S02.00
specific binding protein has been demonstrated in different organs (8) .
It is also known that somatostatin inhibits secretion of glucagon and insulin in the islet cells of the pancreas (9) . In addition to endocrine functions, a paracrine and/or local effect of somatostatin-producing pancreatic D-cells (10) on the glucagon-and insulin-secreting neighbouring cells can be assumed. Immunochemical investigations show that high concentrations of somatostatin are located in the chicken pancreas dark islet cell areas, where large amounts of D-cells can be found (11) . The possibility, however, that somatostatin is secreted in connection with binding proteins has so far received little attention. Since the paracrine actions of somatostatin might be influenced by binding proteins, e.g. carriers and receptors, the biochemical characterization of those proteins is of importance.
We have now been able to demonstrate that a specific somatostatin binding factor occurs in dark islet cell areas of the chicken pancreas.
This paper characterizes the soluble somatostatin binding factor.
Binding assay and separation of bound (B) and free (F) somatostatin
Routinely the following assay was performed (tab. 1): The binding assays were performed with the crude supernatants (cell-free extracts) 600 g> 15 000 g, and 100 000 g. After 2 h incubation time at 4 °C, the reaction was stopped by addition of dextran-coated charcoal The mixtures were agitated for 15 min using a "whirl-mix" and then centrifuged.
Radioactivity of supernatants and charcoal fractions were measured in an automatic gamma counter (Packard 5166) and the B/T-values (total radioactivity, t = B + F) were calculated. Specific binding (B/T) was estimated corresponding to the %-displacement compared with the tubes without excess cyclic somatostatin.
Materials and Methods

Materials
Cyclic somatostatin, cyclic Tyr 1 -somatostatin, and linear somatostatin were purchased from Serono (Freiburg). Lactoperoxidase (EC 1.11.1.7) and reference proteins for the molecular weight determinations were obtained from Boehringer (Mannheim); aprotinin (Trasylol®), Bayer (Leverkusen); insulin, glucagon, luliberin (LH-RH), thyroliberin (TRH), Hoechst (Frankfurt); corticotropin, porcine (ACTH), Ferring (Kiel); AcA 54-® "Urtrogel", LKB (Sweden), and "Sephadex" gels, Pharmacia (Frankfurt); Ion-exchange resin (Dowex 1 X 10) and charcoal Norit A, Serva (Heidelberg) coated with 15% dextran T 40 obtained from Pharmacia (Frankfurt); Na 125 I, Amersham-Buchler (Braunschweig); bovine serum albumin, Bearing (Marburg). All other chemicals (p.a. grade) were purchased from Merck (Darmstadt) or Boehringer (Mannheim) unless otherwise specified in the text Since somatostatin readily absorbs to glass surfaces, incubations were carried out in "Minisorb" tubes from NUNC (Denmark). (12) . Dowex 1 X 10 anion exchange resin and Sephadex G-25 absorption chromatography were used for further purification of the labeled hormone (13) .
Radiolabeling
Gel-filtration
Gel chromatography was done with Ultrogel AcA 54. Phosphate buffer 0.01 mol/i pH 7.5, was applied for elution and the absorption at 280 nm measured continuously unless described otherwise.
Pofyacrylamide disc gel electrophoresis Disc-electrophoresis was performed as described by Davis (15) , pH 8.9-75 g/L A flat gel (3 mm) apparatus from Desaga (Heidelberg) was used. Volumes of 20-60 ìÀ (1-2 g/l protein) of the binding fractions were carefully pipetted into prepolymerized pockets of the spacer gel The samples were mixed with 5 ìÀ 1 mol/1 sucrose to avoid rapid diffusion into the electrode buffer.
Electrophoresis was started with a voltage of 250 V for the first 5 mirij then the potential was stepwise elevated up to 500 V. The electric current decreased slightly during a separation time of 2 h. The flat gel was cut longitudinally and incubated in a fixative stain solution: Coomassie Brilliant Blue R 250 (2.5 g/l) in 125 g/l trichlproacetic acid, or Amido-Black 10 B in 70 g/1 acetic acid. The stained gels were washed and scanned, at 580 nm, or 620 nm, respectively, in a gel scanner from Zeiss. The longitudinal gels were sliced (2 mm pieces) and radioactivity (I25j) was measured in an automatic gamma counter (Packard 5166).
Preparation of cell-free extracts
Adult domestic fowls (Warren-sex-sal-link) were decapitated and bled without anaesthesia. The pancreas was separated from the surrounding tissue. About 0.15 g of the splenic lobe area were cut, weighed and washed with 1 ml 10 mmol/1 tris (hydroxymethyl)-aminomethane/Ha buffer, pH 8.0, 100-500 KIE aprotinin. The pancreatic tissue was homogenized in a twentyfold volume of the same buffer by treatment (20 strokes, 1600 rpm) with a glass-Teflon-homogenatoi at 4 °C. Fractions were frozen and stored below -20 6 C Different areas of the pancreas were worked up in the same manner. Protein was measured according to the method of Bradford (14) , Biorad (M nchen). This maximal binding is reversible as it could be demonstrated by coincubation and preincubation experiments with [ I2s l-Tyr 1 ]somatostatin. However, when cold cyclic somatostatin is preincubated for about 30 min the specific binding (as defined in this paper) increases to 0.11-0.14 (|). It was found that 0.01-0.04 (|) of this binding is irreversible.
Results
Interaction
Usually coincubation of labeled and unlabeled ligands was performed (tab. 1).
The pH-optimum is at pH 8, and equilibrium is reached after 20 h incubation time at 4 °C. For routine determination, a 2 h reaction time has been employed since 0.90 of the maxima] binding is achieved after this incubation time. Cross-reactivity also can be observed with luliberin (LH-RH), which causes 50^displacement at 500 nmol/1. Thyroliberin (TRH), insulin, glucagon, and corticotropin (ACTH) do not interfere effectively. 
Subcellular localization of pancreatic somatostatin binding factor
In order to find out whether the binding factor is a cell membrane, particle-bound substance (e.g. receptor) or whether it is a soluble cytoplasmatic protein, fractionating centrifugation was performed. Binding in supernatants and pellets was determined after differential centrifugations at 6QQg, 15 000 £, and 100 000 £. The total binding increases with the ^-number and is highest in the 100 000 ^-supernatant. The binding capacity of the corresponding pellets remains constant. This suggests that the binding factor is of cytoplasmic origin.
In another attempt to enrich the solubilized binding factor in the cytosol fractions, the protein-solubilizing agent, Triton X-100, was employed. Splenic lobe area (P 3 ) extract was treated with 10 ml/1 Triton X-100 during homogenization.
Following a standard assay, radioactivity was measured in the 15 000 £ fraction. The remaining bound radioactive somatostatin is significantly higher (p < . 2) in the untreated pellet compared with the Triton X-100-treated pellet. In both cases, addition of cold somatostatin before centrifugation causes an increase of binding ( fig.6a ).
In contrast, when cold somatostatin is added to the supernatants, suppression is achieved ( fig. 6b ). Maximal binding capacity is about 0.206, and this is significantly higher (p < 0.01). Suppression in the absence and presence of Triton X-100 is 0.076 and 0.032, respectively ( fig. 6b ). This again suggests that the major binding component is a soluble cytpsol molecule.
Characterization by gel-filtration
For further characterization, the cell-free extract of "P 3 " was fractionated by gel filtration, and the specific binding was measured in the fractions.
AcA 54 with a separation range of 5000-^70 000 was used. The 280 nm absorption^diagram of the AcA 54-chromatography and the corresponding binding values are shown (fig. 7) . In this experiment, incubation of the 100 000 ^-supernatant with somatostatin was done after column chromatography and concentrating of the fig. 7) . Although the addition of Triton-X-100 had been reported to have an influence on gel filtration patterns (16) it was found that the Triton X-100-treated samples have the same specific binding elution peak at = 0.23.
Characterization by polyacrylamide disc gel electrophpresis
In order to elucidate electrophoretic properties of the binding factor by a high resolution separation technique, polyacrylamide disc gel electrophoresis was performed. Typical electropherograms of radioactive somatostatin and the binding incubates are presented in figure 8 . Two main peaks are located: the first at relative mobility -0.6 and the second at = 0.36 ( fig. 8,1 ). For comparison a run with radioactive somatostatin (SRIF) is presented in figure 8 ,2. Here a peak appears at = 0.36. This peak can be totally extracted by treating the gels with trichloroacetic acid ( fig. 8,3 and 8,4) . However, the radioactivity at -0.6 is not extractable and indicates a denatured stable binding complex ( fig. 8,3 ). from the female rat. Schonbrunn & Tashjian (18) described somatostatin receptor binding with cells of the rat pituitary. In both cases, specificity of the binding could be demonstrated. But the differences in the reported thermodynamic data suggest differences in the nature of somatostatin binding.
The highest radioactivity appears in a fraction corresponding to K av = 0.23 in gel filtration; this was shown in experiments in which the specific binding was tested after Ultrogel-fractionation ( fig. 7) . When the fraction cor-As the specific binding capacity which was measured in responding to K av = 0.2 is further separated by discelectrophoresis, the larger peaks at lower relative mobilities suggest that the pancreatic binding factor in the K av = 0.2-fraction is still heterogeneous (fig. 10 ). 
Discussion
Specific binding between cyclic somatostatin and a soluble binding factor has been detected in the chicken pancreas. The highest concentrations of this binding factor have been found in the splenic lobe area (P 3 ). This coincides with a preponderance of the somatostatinproducing D-cells in this part of the organ (11; 17).
Recently, Ogawa et al. (8) found a specific somatostatin binding protein while investigating several tissues, mainly 10 ^g protein) several possible interferring factors should be recognized before further discussion of the binding data.: a) Somatostatin was radiolabeled at the Tyr 1 ^residue of the cyclic tetradecapeptide. This side chain of somatostatin is not as important as other parts for the biological activity of the hormone (19) . It just may be essential for the binding properties described here. Therefore, derivatisation and especially addition of iodine to the Tyr-residue at the N-terminal may diminish the specific binding with the pancreatic binding factor.
In addition, heterogeneity of [ Gel filtration (AcA 54 R Ultrogel) was performed as described in figure 7 . Disc electrophoresis is similar to that demonstrated in figure 8 . The freeze-dried fractions of the gel filtration were redissolved in 50 ìÀ assay-buffer (tab. 1) and incubated with 10 ìÀ [ 125 I-Tyr 1 |somatostatin (900 Bq) for l h at room temperature. 30 ìÀ aliquots were applied. The unstained gels were sliced and radioactivity was measured as described in Materials and Methods. The fraction K& = 0.2 corresponds to the maximal binding (peak) in figure 7.
displacement occurred, and even paradoxical increase of binding was demonstrated in figure 6 , where redissolved cell pellets were incubated with an excess of cold cyclic somatostatin.
The possibility that somatostatin induces a positive cooperation should be considered, but another explanation is given by the fact that somatostatin polymerizes to a high molecular compound, as observed in vitro (20) and in vivo (21) . Weak cross-reactivity with glucagon, insulin and corticotropin has been measured. The remarkably high inhibition by the hypothalamic hormone luliberin is in contrast to the weak effect of thyroliberin. Whether this difference has biological relevance remains unknown.
Nevertheless, several of our results are in good agreement with the work of Ogawa et al. (8) and Ogawa et al. (26) . These authors reported that Ca 2 " 1 " inhibits and EDTA induces the binding. This corresponds to our own observations (tab. 2) and recently was described by Arimura et al. (27) for immunochemical binding.
The disulfide bridge of the somatostatin molecule is likely to play a role in the interaction mechanism (tab. 2). Ogawa et al. (8) suggest a two-step reaction, one reversible event and another irreversible step, which includes the thiol-groups.
Experiments applying the reduced linear form of somatostatin (two HS-groups) show a parallel but less sensitive dose-response curve compared with the oxidized cyclic coriformer (fig. 4) . These experiments were performed under nitrogen. Thus the reoxidation to cyclic somatostatin is unlikely. As reduced glutathione (GSH) inhibits the binding totally and reduces the S-S-bridge of cyclic somatostatin spontaneously (experiments with NADPglutathione oxidoreductase EC 1.6.4.2, not presented) it might be suggested that other arhirio acid residues are involved in the binding mechanism.
The complexity of the binding mechanism is supported by the results of the Scatchard plot ( fig. 5) . Two dissociation constants are calculated, KI = 5.5 · 10" 10 mol/1, which is similar to that found by Schonbrunn & Tashjian (18) for receptor binding, and K 2 = 1.2 · 1¼" 8 mol/1, which is similar to that calculated for the cytosol binding protein presented by Ogawa et al. (8) . In recent work Leitner et al. (28) found K t = 3.3 · 10" 8 mol/1 and K 2 = 7.7 · 10" 6 mol/1 fof binding at anterior pituitary plasma membranes. For further characterization of the pancreatic binding factor column ehromatography was performed. Although this gel filtration technique is similar to that which was carried out by Ogawa et al. (8) , there is a discrepancy between our own molecular weight estimation (M r = 40 000) and that reported by these authors (M r = 80 000). In our work, an Ultrogel AcA 54 separation range 5000-70 000 and different elution systems were used. Additional experiments have to be done for a precise estimation of the molecular weight.
In addition, fractional centrifugation and treatment with solubilizer Triton X-100 were performed. Highest values of specific binding were found in the 100 000 £ cytosol fractions, which were free from mitochondria and membrane fragments (electron microscopy experiments, supplied by Dr. H. Pickartz). Since it was impossible to enrich the binding capacity by treatment of "P 3 " extract with Triton X-100, it can be suggested that the binding factor is a soluble and not a particle bound (e.g. receptor) protein.
The disc electrophoresis experiments, which are presented in figures 8-10, indicate the existence of a stable soluble somatostatin binding complex. The relative mobility is about 0.6. Ogawa et al. (26) reported -0.7.
As monomeric somatostatin possesses a high isoelectric point, 9.5, Diel et al. (13) , and 10-10.4, Conlon et al. (25) , it does not migrate into the polyacrylamide gel unter the described circumstances. However, extractable radioactivity appears in a distinct peak,'relative mobility = 0.36, when running [ 125 I-Tyr l ]somatostatin alone. This may be due to self-polymerization and selfaggregation, and therefore, to a change of its physicochemical character (20) .
Finally, the present data do not allow any conclusions about the regulatory effects of the binding factor in respect to the local functions between the different cells of the pancreatic islets. Although a specific protein binding assay for somatostatin could be developed using the pancreatic binding factor (29), described here, further work is necessary to elucidate details of the specific binding of somatostatin, to classify whether the binding factor acts as a carrier protein, and whether specific receptors are located at the islet cells of the pancreas.
